CME Group EBIT Margin 2010-2023 | CME
Current and historical EBIT (Earnings Before Interest & Taxes) margin for CME Group (CME) over the last 10 years. The current EBIT profit margin for CME Group as of December 31, 2023 is .
| CME Group EBIT Margin Historical Data |
| Date |
TTM Revenue |
TTM EBIT |
EBIT Margin |
| 2023-12-31 |
$5.58B |
$3.44B |
61.59% |
| 2023-09-30 |
$5.35B |
$3.24B |
60.60% |
| 2023-06-30 |
$5.24B |
$3.16B |
60.33% |
| 2023-03-31 |
$5.12B |
$3.07B |
60.04% |
| 2022-12-31 |
$5.02B |
$3.02B |
60.08% |
| 2022-09-30 |
$4.96B |
$2.98B |
60.09% |
| 2022-06-30 |
$4.84B |
$2.86B |
58.98% |
| 2022-03-31 |
$4.78B |
$2.78B |
58.12% |
| 2021-12-31 |
$4.69B |
$2.65B |
56.43% |
| 2021-09-30 |
$4.64B |
$2.53B |
54.49% |
| 2021-06-30 |
$4.61B |
$2.44B |
52.91% |
| 2021-03-31 |
$4.62B |
$2.40B |
52.07% |
| 2020-12-31 |
$4.88B |
$2.64B |
54.01% |
| 2020-09-30 |
$4.92B |
$2.70B |
54.76% |
| 2020-06-30 |
$5.12B |
$2.86B |
55.79% |
| 2020-03-31 |
$5.21B |
$2.92B |
55.99% |
| 2019-12-31 |
$4.87B |
$2.59B |
53.16% |
| 2019-09-30 |
$4.97B |
$2.67B |
53.65% |
| 2019-06-30 |
$4.59B |
$2.53B |
55.07% |
| 2019-03-31 |
$4.38B |
$2.50B |
57.02% |
| 2018-12-31 |
$4.31B |
$2.61B |
60.51% |
| 2018-09-30 |
$3.97B |
$2.50B |
62.80% |
| 2018-06-30 |
$3.96B |
$2.51B |
63.46% |
| 2018-03-31 |
$3.83B |
$2.45B |
64.08% |
| 2017-12-31 |
$3.65B |
$2.31B |
63.40% |
| 2017-09-30 |
$3.66B |
$2.31B |
63.20% |
| 2017-06-30 |
$3.61B |
$2.27B |
62.87% |
| 2017-03-31 |
$3.59B |
$2.23B |
62.03% |
| 2016-12-31 |
$3.60B |
$2.20B |
61.20% |
| 2016-09-30 |
$3.50B |
$2.13B |
60.98% |
| 2016-06-30 |
$3.50B |
$2.12B |
60.59% |
| 2016-03-31 |
$3.42B |
$2.06B |
60.12% |
| 2015-12-31 |
$3.33B |
$1.99B |
59.75% |
| 2015-09-30 |
$3.35B |
$1.99B |
59.33% |
| 2015-06-30 |
$3.27B |
$1.90B |
58.30% |
| 2015-03-31 |
$3.18B |
$1.82B |
57.30% |
| 2014-12-31 |
$3.11B |
$1.77B |
56.84% |
| 2014-09-30 |
$2.96B |
$1.62B |
54.77% |
| 2014-06-30 |
$2.91B |
$1.59B |
54.65% |
| 2014-03-31 |
$3.00B |
$1.69B |
56.33% |
| 2013-12-31 |
$2.94B |
$1.64B |
55.77% |
| 2013-09-30 |
$2.91B |
$1.69B |
58.09% |
| 2013-06-30 |
$2.88B |
$1.69B |
58.56% |
| 2013-03-31 |
$2.86B |
$1.65B |
57.61% |
| 2012-12-31 |
$2.92B |
$1.69B |
58.04% |
| 2012-09-30 |
$2.99B |
$1.71B |
57.04% |
| 2012-06-30 |
$3.18B |
$1.88B |
59.15% |
| 2012-03-31 |
$3.22B |
$1.95B |
60.42% |
| 2011-12-31 |
$3.28B |
$2.02B |
61.60% |
| 2011-09-30 |
$3.31B |
$2.09B |
63.17% |
| 2011-06-30 |
$3.17B |
$1.96B |
61.91% |
| 2011-03-31 |
$3.14B |
$1.94B |
61.74% |
| 2010-12-31 |
$3.00B |
$1.83B |
60.97% |
| 2010-09-30 |
$2.91B |
$1.78B |
61.07% |
| 2010-06-30 |
$2.83B |
$1.73B |
61.38% |
| 2010-03-31 |
$2.66B |
$1.62B |
60.85% |
| 2009-12-31 |
$2.61B |
$1.59B |
60.81% |
| Sector |
Industry |
Market Cap |
Revenue |
| Finance |
Securities Exchanges |
$76.693B |
$5.579B |
|
CME Group is the largest futures exchange in the world in terms of trading volume as well as notional value traded. CME Group offers a broad range of products covering major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. Trades are executed through CME Group's electronic trading platforms, open outcry and privately negotiated transactions. CME Group also operates one of the world's leading central counterparty clearing providers through CME Clearing and CME Clearing Europe, which offer clearing and settlement services across asset classes for exchange-traded and over-the-counter derivatives. Apart from CME and CBOT, the company operates New York Mercantile Exchange, Inc. (NYMEX) and Commodity Exchange, Inc. (COMEX), CME Clearing Europe Limited (CMECE) and CME Europe Limited (CME Europe). The company reports the results of its operations as one operating segment mainly comprised of CME, CBOT, NYMEX and COMEX.
|
